Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours Β· Estimated delivery Aug 15 - Aug 20
No New Drug Application (NDA) or Biologics License Application (BLA) for BPC-157 has been submitted or approved by the agency
Current standard-of-care treatments focus primarily on preventing secondary damage through surgical intervention and supportive care
For years, most care leaned on a small set of options like minoxidil and finasteride, plus procedures, so the field became focused on optimization rather than entirely new pathways. Immune-mediated hair loss conditions such as alopecia areata (AA) have seen more recent advances, but even here, durable and well-tolerated options remain limited
Your body is going to respond
The BPC-157 Layer: Addresses the structural side (protecting the gut lining from the GI distress GLP-1s often cause, and potentially mitigating the severe muscle loss that accompanies rapid weight reduction)
RUOlabeled products cannot be marketed with clinical claims, and using them in patient care can subject the materialand the userto FDA drug or device requirements
US$ 23.41
US$ 26.52
US$ 20.27
US$ 22.07
US$ 25.57
US$ 25.05
